2 Bay Area biotechs raise nearly $460M in target-topping IPOs

They join a group of new Bay Area biotech stocks that have risen by between 47% and 162%, based on Thursday's closing prices.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.